DTE
45
-2
CHRW
57
7
CAT
55
-3
SYY
48
-2
CHD
32
-2
DG
17
-4
PCG
59
3
NOV
40
-3
ADT
33
-4
STZ
52
-3
VRSK
66
3
DE
53
-3
WFC
60
-3
SWK
52
-3
UPS
53
2
REGN
45
-3
ZION
60
-3
VFC
53
-3
THC
54
-2
BMY
46
-2
DTE
45
-2
CHRW
57
7
CAT
55
-3
SYY
48
-2
CHD
32
-2
DG
17
-4
PCG
59
3
NOV
40
-3
ADT
33
-4
STZ
52
-3
VRSK
66
3
DE
53
-3
WFC
60
-3
SWK
52
-3
UPS
53
2
REGN
45
-3
ZION
60
-3
VFC
53
-3
THC
54
-2
BMY
46
-2
Financhill
Back

UroGen Pharma Stock Predictions

Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!

Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)
Sell
43

URGN
UroGen Pharma

Last Price:
11.36
Seasonality Move:
5.08%

7 Day Trial

ALL ACCESS PASS

$ 7

The dark truth about AI

Click here to learn more...

UroGen Pharma Stock Forecast

  • Over the next 52 weeks, UroGen Pharma has on average historically fallen by 9.2% based on the past 7 years of stock performance.
  • UroGen Pharma has fallen lower in 5 of those 7 years over the subsequent 52-week period, corresponding to a historical accuracy of 71.43%
  • Is UroGen Pharma Stock Undervalued?
    The current UroGen Pharma [URGN] share price is $11.47. The Score for URGN is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • URGN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will UroGen Pharma Stock Go Up Next Year?

  • Over the next 52 weeks, UroGen Pharma has on average historically fallen by 9.2% based on the past 7 years of stock performance.

UroGen Pharma Stock Rating

Sell
43
UroGen Pharma (URGN) is a Sell

Is UroGen Pharma overpriced?

  • UroGen Pharma has fallen lower in 5 of those 7 years over the subsequent 52-week period, corresponding to a historical accuracy of 71.43%

UroGen Pharma Stock Price History

Is URGN stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and URGN is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
urogen.com

52-Week Data

52-Week High:
20.70
52-Week Low:
10.60

Prediction Charts

Market Cap:
484.03M
Price in USD:
11.47
Volume:
325.33K
Beta:
1.12

Technical Analysis

SMA50:
12.21
SMA100:
13.27
SMA200:
14.16
52-Wk Change:
-23.79%

Stock Predictions

  • Is UroGen Pharma stock public?
    Yes, UroGen Pharma is a publicly traded company.
  • What is the UroGen Pharma stock quote today?
    The UroGen Pharma stock price is 11.47 USD today.
  • How to buy UroGen Pharma stock online?
    You can buy UroGen Pharma shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-22 11.60 11.91 12.04 11.50
Nov-25 12.20 12.48 12.57 12.01
Nov-26 12.40 12.48 12.65 12.06
Nov-27 12.46 12.66 12.91 12.34
Nov-29 12.40 12.70 12.78 12.00
Dec-2 12.76 12.88 13.13 12.70
Dec-3 12.86 12.34 12.91 12.23
Dec-4 12.35 12.46 12.79 12.23
Dec-5 12.46 12.21 12.75 12.11
Dec-6 12.46 12.29 12.68 12.25
Dec-9 12.29 12.17 12.57 12.09
Dec-10 12.14 12.04 12.21 11.83
Dec-11 12.04 11.44 12.04 11.33
Dec-12 11.30 11.47 11.68 11.24

UroGen Pharma Earnings

UroGen Pharma Earnings Report: Per Share UroGen Pharma Earnings Q1 Q2 Q3 and Q4 last year and next year.

UroGen Pharma Forecast Revenue Growth

UroGen Pharma Stock Analysis: Historical quarterly revenues per share for UroGen Pharma and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.48 per share, and an increase next year of $0.42 per share.

* UroGen Pharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.